Optic Neuritis Completed Phase 2 / 3 Trials for Dalfampridine (DB06637)

Also known as: Optical Neuritis / Unspecified optic neuritis / Optic neuritis NOS / Optic neuritis, unspecified / Neuritis optic

IndicationStatusPhase
DBCOND0027863 (Optic Neuritis)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01337986Ampyra for Optic Neuritis in Multiple SclerosisTreatment